drugset / Trial / NCT00307580
Cathflo Activase Pediatric Study
Treatment
Summary
This was a Phase IV, open-label, single-arm, multicenter trial that was to be conducted at \~60 sites in the United States. Approximately 300 pediatric subjects with dysfunctional CVADs (including catheters with valves, multiple lumens, umbilical catheters, and implanted ports) were to be treated with up to two serially instilled doses of Cathflo Activase.
Timeline
- Start
- 2002-04
- Primary completion
- —
- Completion
- 2003-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alteplase | Protein / enzyme biologic | — | — |
Indications
No indication recorded.